SALT LAKE CITY – November 3, 2023 - BioUtah today announced the winners of its 2023 Life Sciences Awards. Five awards will be presented during the 2023 Mayer Brown Utah Life Sciences Summit Nov. 9 at the Salt Palace, in Salt Lake City. BioUtah’s annual awards recognize leaders...

FOR IMMEDIATE RELEASE SALT LAKE CITY, July 27, 2023 – Proposed expansions of federal government-mandated drug pricing policies present serious consequences for the development of and investment in new medicines, and significant job losses in major innovation hubs such as Utah,...

Salt Lake City- March, 21, 2023 - BioUtah today applauds nView Medical and Birch OS, the winner and runner up, respectively, of the Pitch Competition held March 16 during the 2023 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit). The E&I Summit, present...

Salt Lake City, March 9 - BioUtah, Utah’s only trade association dedicated solely to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center, today announced the six Utah life sciences startup comp...

Salt Lake City - January 24 - BioUtah, Utah’s trade association dedicated to the life sciences, in partnership with the University of Utah’s Partners for Innovation, Ventures, Outreach & Technology (PIVOT) Center and BioHive today announced its distinguished keynote speaker, J...

Gisela joined Oncocyte in October 2021 as the firm’s Chief Operating Officer and was promoted to President and Chief Operating Officer in August 2022. She brings a wealth of knowledge and first-hand experience, leading large-scale operations at global pharmaceutical and diagno...

Welcome, everyone.  I’ll begin by reviewing recent decisions and actions we are taking to reduce our operating expenses and cash burn enabling us to weather the current market conditions while still delivering on the important product launches that will deliver significant sha...

Boston, MA – September 16, 2022 – Reportable launched a new Life Science Intelligence software for biopharma, diagnostics and medical device companies to seamlessly track business developments and scientific advancements. Custom briefs consolidate multiple disparate informatio...

Ronald Andrews Welcome, everyone, to today's call. We're very excited to walk you through what we believe is a transformational opportunity for our Company. Today, as Bob mentioned, given the timeframe for regulating various products, we are going to be talking and giving a n...

Wall Street biopharma investment bank equity research analysts, colloquially called sell-side analysts, are an interesting bunch. For all intents and purposes, the main qualification for the job is that you are always bullish. In fact, the preverbal sell-side euphemism for whe...